Detalles de la búsqueda
1.
[Combination of Jianpi Liqi Yiliu Formula with Cytokine-induced Killer Cell Treatment for Advanced Hepatocellular Carcinoma].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 36(2): 160-5, 2016 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-27078990
2.
[Treating primary liver cancer patients by Pi-strengthening and Qi-regulating method: univariate and multivariate analyses of their prognoses].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 34(2): 162-6, 2014 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-24672939
3.
[The distribution of Chinese medicine syndrome types in primary liver cancer and their differences of the survival time: a clinical study].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 33(7): 911-4, 2013 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-24063211
4.
Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.
Chin J Integr Med
; 24(10): 734-740, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28795387
5.
Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Trials
; 16: 146, 2015 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25873045
6.
[Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy].
Nan Fang Yi Ke Da Xue Xue Bao
; 31(12): 2090-2, 2011 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-22200721
7.
Treatment of advanced non-small cell lung cancer with extracorporeal high frequency thermotherapy combined with Chinese medicine.
Chin J Integr Med
; 16(5): 406-10, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20872115
Resultados
1 -
7
de 7
1
Próxima >
>>